CDC - Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States

	EID Home \| Upcoming Issues and Ahead-of-Print Articles \| Past Issues \| EID Search \| Contact Us *Research* Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States John A. Jernigan,* David S. Stephens,† David A. Ashford, Carlos Omenaca,‡ Martin S. Topiel,§ Mark Galbraith,¶ Michael Tapper,# Tamara L. Fisk,† Sherif Zaki, Tanja Popovic,* Richard F. Meyer,* Conrad P. Quinn,* Scott A. Harper,* Scott K. Fridkin,James J. Sejvar, Colin W. Shepard,* Michelle McConnell,* Jeannette Guarner,* Wun-Ju Shieh,* Jean M. Malecki,** Julie L. Gerberding,* James M. Hughes,* Bradley A. Perkins,* and members of the Anthrax Bioterrorism Investigation Team⁽¹⁾Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Emory University School of Medicine, Atlanta, Georgia, USA; ‡Cedars Medical Center, Miami, Florida, USA; §Virtua Health, Mount Holly, New Jersey, USA; ¶Winchester Medical Center, Winchester, Virginia, USA; #Lenox Hill Hospital, New York City, New York, USA; and *Palm Beach County Department of Public Health, West Palm Beach, Florida, USA

	Back to article Figure 7A. Pleural fluid cell block from a nonfatal case showing abundant Bacillus anthracis granular antigen staining inside mononuclear inflammatory cells. (Immunohistochemical assay with a mouse monoclonal anti-B. anthracis capsule antibody and detection with alkaline phosphatase and naphthol fast red, original magnification 158X).

	Home *\| Top of Page \| Current Issue \| Expedited* \| Upcoming Issue \| Past Issue \| EID Search \| Contact Us \| Accessibility \| Privacy Policy Notice \| CDC Home \| Search \| Health Topics A-Z** This page last reviewed December 08, 2001 Emerging Infectious Diseases Journal National Center for Infectious Diseases Centers for Disease Control and Prevention